Behan P O, Shakir R A, Simpson J A, Burnett A K, Allan T L, Haase G
Lancet. 1979 Sep 1;2(8140):438-40. doi: 10.1016/s0140-6736(79)91492-2.
Twenty-one patients with myasthenia gravis underwent a course of plasma exchange combined with immunosuppressive therapy. In fifteen there was dramatic clinical improvement which has been maintained for periods up to 19 months. Nine of these patients now take no anticholinesterase drugs. Six patients had a recurrence 3--9 months after the first course but in the three given a second course remissions were again obtained.
21例重症肌无力患者接受了血浆置换联合免疫抑制治疗。其中15例临床症状显著改善,且持续改善长达19个月。这些患者中有9例目前无需服用抗胆碱酯酶药物。6例患者在第一个疗程后3至9个月复发,但接受第二个疗程的3例患者再次获得缓解。